✦ LIBER ✦

Overexpression of annexin 1 in the development and differentiation of urothelial carcinoma

✍ Scribed by Wan-Yi Kang; Wan-Tzu Chen; Ya-Chun Huang; Yue-Chiu Su; Chee-Yin Chai

Book ID: 119316933
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 581 KB
Volume: 28
Category: Article
ISSN: 0257-5655
DOI: 10.1016/j.kjms.2011.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overexpression of p27kip1 in urinary bla

Overexpression of p27kip1 in urinary bladder urothelial carcinoma

✍ Ting-Ying Fu; Ming-Shium Tu; Hui-Hwa Tseng; Jyh-Seng Wang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

139 Overexpression of Drosha, Argonaute

139 Overexpression of Drosha, Argonaute 1 and 2 in patients with urothelial carcinomas

✍ Ratert, N.; Jung, K.; Erbersdobler, A.; Kilic, E.; Ecke, T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 200 KB

The prognostic value of MDM2 overexpress

The prognostic value of MDM2 overexpression in superficial urothelial bladder carcinoma

✍ Lucio Lara Santos; Marta Koch Pereira; Céu Silva Costa; Teresina Pinto Amaro; Ca 📂 Article 📅 2002 🏛 Springer Milan 🌐 Spanish ⚖ 105 KB

Long intergenic non-coding RNA TUG1 is o

Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder

✍ Yonghua Han; Yuchen Liu; Yaoting Gui; Zhiming Cai 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Overexpression of RIN1 associates with t

Overexpression of RIN1 associates with tumor grade and progression in patients of bladder urothelial carcinoma

✍ Shan, Guang-yi; Zhang, Zhe; Chen, Qi-guang; Yu, Xiu-yue; Liu, Guo-bin; Kong, Chu 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 394 KB

HER2 overexpression in muscle-invasive u

HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: Prognostic implications

✍ Stefan Krüger; Georg Weitsch; Hartwig Büttner; Arne Matthiensen; Torsten Böhmer; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 392 KB

## Abstract The HER2 (c‐erbB‐2) receptor is overexpressed in a variety of human malignant tumors and, in breast carcinoma, has been identified as a target for anti‐HER2–directed therapy with the monoclonal antibody (MAb) trastuzumab. The aim of this retrospective study was to evaluate immunohistoch